Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients.
Abbott says all four segments stronger than pre-pandemic
By the numbers Q4 revenue: $10.24 billion 1.5% increase year over year 2023 revenue: $40.11 billion 8.1% decrease year over year Q4 net earnings: $1.59
January 24, 2024